{"id":510199,"date":"2021-07-07T08:04:05","date_gmt":"2021-07-07T12:04:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/"},"modified":"2021-07-07T08:04:05","modified_gmt":"2021-07-07T12:04:05","slug":"viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/","title":{"rendered":"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference"},"content":{"rendered":"
\n

BOULDER, Colo., July 07, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will present a company overview at the virtual Ladenburg Thalmann 2021 Healthcare Conference taking place July 13 \u2013 14, 2021.<\/p>\n\n\n\n\n
\n Event:<\/strong>\n <\/td>\n\n Ladenburg Thalmann 2021 Healthcare Conference<\/strong>\n <\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\nWednesday, July 14<\/td>\n<\/tr>\n
\n Presentation Time:<\/strong>\n <\/td>\n9:00 a.m. ET<\/td>\n<\/tr>\n<\/table>\n

The webcast information for this event will be accessible on the Events page under the Investors section of the Viridian Therapeutics website at\u00a0www.viridiantherapeutics.com<\/a>. A replay of the presentation will be archived on the website and available for approximately 90 days following the live event.<\/p>\n

\n About Viridian Therapeutics<\/strong>\n <\/p>\n

Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies. Viridian\u2019s most advanced program, VRDN-001, is an anti-IGF-1R monoclonal antibody in development for TED, a debilitating auto-immune disease that causes inflammation and fibrosis within the orbit of the eye which can cause double vision, pain, and potential blindness. Patients with severe disease often require multiple remedial surgeries to the orbit, eye muscles, and eyelids. Viridian is based in Boulder, Colorado, and Waltham, Massachusetts. Learn more about Viridian and its programs at https:\/\/www.viridiantherapeutics.com\/<\/a>.<\/p>\n

Follow us on Twitter @ViridianThera and on LinkedIn.<\/p>\n

\n Viridian Contacts:<\/strong>
\n
\n Investors:<\/strong>
\n
Dan Ferry
LifeSci Advisors
617-430-7576
IR@viridiantherapeutics.com<\/a><\/p>\n

\n Media:<\/strong>
\n
Darby Pearson
Verge Scientific Communications
703-587-0831
PR@viridiantherapeutics.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BOULDER, Colo., July 07, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will present a company overview at the virtual Ladenburg Thalmann 2021 Healthcare Conference taking place July 13 \u2013 14, 2021. Event: Ladenburg Thalmann 2021 Healthcare Conference Date: Wednesday, July 14 Presentation Time: 9:00 a.m. ET The webcast information for this event will be accessible on the Events page under the Investors section of the Viridian Therapeutics website at\u00a0www.viridiantherapeutics.com. A replay of the presentation will be archived on the website and available for approximately 90 days following the … <\/p>\n

Continue reading “Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-510199","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nViridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOULDER, Colo., July 07, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will present a company overview at the virtual Ladenburg Thalmann 2021 Healthcare Conference taking place July 13 \u2013 14, 2021. Event: Ladenburg Thalmann 2021 Healthcare Conference Date: Wednesday, July 14 Presentation Time: 9:00 a.m. ET The webcast information for this event will be accessible on the Events page under the Investors section of the Viridian Therapeutics website at\u00a0www.viridiantherapeutics.com. A replay of the presentation will be archived on the website and available for approximately 90 days following the … Continue reading "Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-07T12:04:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference\",\"datePublished\":\"2021-07-07T12:04:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/\"},\"wordCount\":257,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/\",\"name\":\"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=\",\"datePublished\":\"2021-07-07T12:04:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk","og_description":"BOULDER, Colo., July 07, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer of Viridian, will present a company overview at the virtual Ladenburg Thalmann 2021 Healthcare Conference taking place July 13 \u2013 14, 2021. Event: Ladenburg Thalmann 2021 Healthcare Conference Date: Wednesday, July 14 Presentation Time: 9:00 a.m. ET The webcast information for this event will be accessible on the Events page under the Investors section of the Viridian Therapeutics website at\u00a0www.viridiantherapeutics.com. A replay of the presentation will be archived on the website and available for approximately 90 days following the … Continue reading \"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-07T12:04:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference","datePublished":"2021-07-07T12:04:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/"},"wordCount":257,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/","name":"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=","datePublished":"2021-07-07T12:04:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NTg5NCM0Mjg0NTEzIzIwMjc5NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=510199"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/510199\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=510199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=510199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=510199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}